Star Therapeutics, a biotechnology company interrogating novel biology to develop life-changing therapies, today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present a company overview at the 42^nd annual J.P. Morgan Healthcare Conference on Thursday, January 11^th at 10:30 a.m. PT. The conference is being held in San Francisco from January 8-11, 2024.

About Star Therapeutics

Star Therapeutics is a biotechnology company that interrogates areas of novel biology to develop life-changing therapies for as many patients as possible, initially addressing unmet needs in hematology and immunology. The company’s engine for innovation starts with identifying multiple diseases that share a common biology and then discovering novel therapeutics that can treat numerous diseases with a single therapy. Star consists of a constellation of companies, each focused on a specific area of biology with first-in-class therapies. Star is backed by leading life sciences investors and located in South San Francisco. For more information, please visit www.star-therapeutics.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240102369613/en/